Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Condensed Consolidated Statements of Operations
Grant revenue	$ 491	$ 966
Operating expenses
Research and development	5,429	8,016
General and administrative	3,253	3,178
Total operating expenses	8,682	11,194
Operating loss	(8,191)	(10,228)
Other income (expense)
Interest income	59	52
Interest expense	(3,602)	(1,820)
Change in fair value of the Convertible Loan	5,203	(13,025)
Total other income (expense), net	1,660	(14,793)
Net loss	$ (6,531)	$ (25,021)
Per share information:
Net loss per share, basic	$ (0.18)	$ (0.69)
Weighted average shares outstanding, basic	36,184,802	36,124,980
Net loss per share, diluted	$ (0.2)	$ (0.69)
Weighted average shares outstanding, diluted	59,478,662	36,124,980